Navigation Links
Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
Date:6/24/2008

SOUTH SAN FRANCISCO, Calif., June 24 /PRNewswire/ -- Portola Pharmaceuticals, a clinical-stage biopharmaceutical developing best-in-class therapeutics for acute and chronic cardiovascular and inflammatory diseases, today announced that Bill Lis has joined the company as Vice President of Business and Commercial Development. Mr. Lis will be responsible for the company's corporate partnering activities as well as commercial strategy for Portola's portfolio of clinical and preclinical programs. He will join the company's executive management team.

Mr. Lis has over 17 years of experience in biopharmaceutical and medical device sales & marketing, medical affairs, and business development. From 2005 until 2008 he was Vice President, Business and New Product Development, Scios, Inc. (A Johnson and Johnson Company) where, most recently, he was responsible for cardiovascular business licensing strategies and activities and commercial operations. He led successful in-licensing activities and pre-market and commercial infrastructure development for Xarelto(R) (rivaroxaban) a Phase III drug candidate, filed for EMEA regulatory approval. Prior to joining Scios, he was Director of Marketing and New Products, Millennium Pharmaceuticals, Inc. where he held positions of increasing leadership, including the management of marketing activities for Integrilin(R) (eptifibatide), a best in class antithrombotic drug. Previously, at Rhone Poulenc Rorer and Ethicon Endo Surgery he was involved in the launch and commercialization of several products, including Lovenox(R) (enoxaparin). He holds a B.S. in Finance from the University of Maryland.

About Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals, Inc. is a privately-held biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular disease. Portola has two antithrombotic drug candidates in Phase II clinical development. Port
'/>"/>

SOURCE Portola Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Due to a misstatement posted by the Family ... Technology Center, LLC ( ASCTC ) was reported as an ... might benefit ALS patients. Because of ASCTC's exclusive focus ... and therapeutic applications, FRC listed ASCTC as one of several ... wish not to support research that requires the death of ...
(Date:8/28/2014)... City, CA (PRWEB) August 28, 2014 ... sanitation products for the food processing industry, is asking ... a side-by side comparison of the E2 soap they’re ... E2 Sanitizing Foam Soap . Hand hygiene is ... in the food processing environment. Six key criteria are ...
(Date:8/28/2014)... Spin-charge converters are important devices in spintronics, an ... charge of electrons but also on their spin ... transformation of electric into magnetic signals and vice ... Sinova from the Institute of Physics at Johannes ... the UK, Prague, and Japan, has for the ...
(Date:8/28/2014)... 2014   SunTrust Robinson Humphrey (STRH) ... to its equity research team in biotechnology and ... in equity research demonstrates our commitment to providing ... enhance their investment decision making," said Biff ... continue to make significant investments in differentiated content ...
Breaking Biology Technology:The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2A new, tunable device for spintronics 2A new, tunable device for spintronics 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3
... S*BIO Pte Ltd today announced that,the U.S. Food ... to SB1518, its potent and orally-active JAK2 inhibitor ... accepted S*BIO,s,application upon review of preclinical data which ... good,tolerability of the JAK2 inhibitor., "We are ...
... government responsible for coordinating nanotechnology research and regulations across ... State University to craft a white paper that will ... potential risks associated with nanotechnology to the media and ... has been negotiating this project for nearly 18 months. ...
... MGT Capital Investments,Inc. (AMEX: MGT ), a ... ("HCIT") sector, today reported financial results,for the first ... update on,strategic milestones., Tim Paterson-Brown, MGT Chairman ... significant turning point for our subsidiaries, Medicsight and,Medicexchange. ...
Cached Biology Technology:S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders 2Federal government taps NC State experts to explain nanotech risks 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 4
(Date:8/29/2014)... - The rise of the Tibetan plateau -- the ... is important for both its profound effect on climate ... published in GSA Bulletin , Katharine Huntington and ... thermometry -- using modern and fossil snail shells to ... southwestern Tibet. , Views range widely on the ...
(Date:8/28/2014)... bacterial culprits that may drive inflammatory bowel diseases (IBD) ... own intestinal immune responses as a guide. , The ... Cell . , Trillions of bacteria exist within the ... the development and progression of IBD. Yet it,s thought ... a person,s susceptibility to IBD and its potential severity. ...
(Date:8/28/2014)... neighbors than traditional cigarettes, but still release toxins ... from USC. , Scientists studying secondhand smoke from ... to harmful particles, with close-to-zero exposure to organic ... metals in second-hand e-cigarette smoke were found to ... high levels of polycyclic aromatic hydrocarbons cancer-causing ...
Breaking Biology News(10 mins):Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7Yale study identifies possible bacterial drivers of IBD 2Second-hand e-cig smoke compared to regular cigarette smoke 2
... mating performance in a tropical sea slug, Chelidonura ... now shed light on the bizarre reproductive conflicts ... such as C. hirundinina, mating partners may insist ... resulting in unique biological conflicts over gender. , ...
... of soldiers guarding a castle gate, multiple genetic defenders ... according to a new study. Powdery mildew is a ... 9,000 species, including many crops such as barley and ... The researchers, including Shauna Somerville and Mónica Stein of ...
... other biological attributes, is shaped by evolution through ... that are in other ways very similar might ... visual world slightly differently, using photoreceptors that are ... a special group of closely-related fish species inhabiting ...
Cached Biology News:Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3Multiple genes permit closely related fish species to mix and match their color vision 2
... Well BAC Prep; Ideal for ... 1.5ml 2xYT cultures; Provides high-quality ... sequencing for small to large ... which minimizes shearing and improves ...
Vesicular Glutamate Transporter 2 [VGLUT2]...
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778 ...
XIAP Antibody...
Biology Products: